chr11-108331498-G-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PP3_StrongPP5_Very_Strong
The NM_000051.4(ATM):āc.7570G>Cā(p.Ala2524Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,613,158 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 32)
Exomes š: 0.0000096 ( 0 hom. )
Consequence
ATM
NM_000051.4 missense
NM_000051.4 missense
Scores
11
7
1
Clinical Significance
Conservation
PhyloP100: 9.69
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
C11orf65 (HGNC:28519): (chromosome 11 open reading frame 65) Predicted to be involved in negative regulation of mitochondrial fission and negative regulation of protein targeting to mitochondrion. Predicted to be located in cytosol and mitochondrial outer membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.971
PP5
Variant 11-108331498-G-C is Pathogenic according to our data. Variant chr11-108331498-G-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 187613.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.7570G>C | p.Ala2524Pro | missense_variant | 51/63 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151792Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
151792
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251298Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135844
GnomAD3 exomes
AF:
AC:
6
AN:
251298
Hom.:
AF XY:
AC XY:
3
AN XY:
135844
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461366Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 726986
GnomAD4 exome
AF:
AC:
14
AN:
1461366
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
726986
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151792Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74124
GnomAD4 genome
AF:
AC:
1
AN:
151792
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74124
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Ataxia-telangiectasia syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 06, 2024 | This sequence change replaces alanine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 2524 of the ATM protein (p.Ala2524Pro). This variant is present in population databases (rs769142993, gnomAD 0.03%). This missense change has been observed in individual(s) with ataxia-telangiectasia and/or ATM-related cancers (PMID: 10980530, 11897822, 16622469). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 187613). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects ATM function (PMID: 17166884, 22071889). For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 20, 2024 | Observed in the compound heterozygous or homozygous state in multiple unrelated patients with ataxia-telangiectasia, and confirmed to be on the opposite allele (in trans) with a pathogenic variant in at least one individual (PMID: 10980530, 11897822, 22071889); Published functional studies suggest a damaging effect: defective kinase activity (PMID: 17166884, 22071889); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 16622469, 16914028, 30927251, 32853339, 35095854, 33436325, 32183364, 29922827, 36467798, 20346647, 11897822, 10980530, 19224889, 22071889, 17166884, 23532176, 36551643, 36161273, 37578974) - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 25, 2022 | The p.A2524P variant (also known as c.7570G>C), located in coding exon 50 of the ATM gene, results from a G to C substitution at nucleotide position 7570. The alanine at codon 2524 is replaced by proline, an amino acid with highly similar properties. This alteration was observed in two Finnish ataxia telangiectasia (AT) families (Allinen M et al. J Med Genet. 2002 Mar;39(3):192-6). This alteration has also been observed as heterozygous in multiple individuals diagnosed with breast or prostate cancer (Allinen M et al. J Med Genet. 2002 Mar;39(3):192-6; Bubien V et al. Genes Chromosomes Cancer. 2017 Nov;56(11):788-799; Nurmi A et al. Int. J. Cancer, 2019 11;145:2692-2700; Rantapero T et al. Genes (Basel), 2020 03;11:; Karlsson Q et al. Eur Urol Oncol, 2021 Aug;4:570-579). One functional study demonstrated that this alteration leads to a stable protein that is defective in kinase activity (Pylkas K et al. Carcinogenesis. 2007 May;28(5):1040-5). A second functional study demonstrated that this alteration leads to a significantly decreased response to ionizing radiation that is similar to that of a control AT cell line (Jacquemin V et al. Eur J Hum Genet. 2012 Mar;20(3):305-12). One meta-analysis provided a rough estimate that this alteration may confer a 7-fold increased risk for breast cancer over the general population (Hollestelle A et al. Curr Opin Genet Dev. 2010 Jun;20(3):268-76). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;.
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;M
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MutPred
Loss of MoRF binding (P = 0.0532);Loss of MoRF binding (P = 0.0532);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at